Multiple myeloma is one of the most widespread hemoblastosis. In the structure of oncohematology it takes up about 10%. It follows with destruction of bones and results in lethal outcome. Ostealgia’s syndrome is leading in more than 70% of patients at the beginning of this medical condition. Damage of the skeleton is found at 80% of patients by means of X-ray. Patients suffer from decrease of osseous tissue mineral density and increase in level markers of osseous resorption and elaboration (bones acid and alcaline phosphatases, desoxypiridoline). These indices can be used as predictors of efficiency and safety of treatment of osteopenia in patients with multiple myeloma
A.A. Svistunov, A.V. Ruta, O.V. Shevchenko Peculiarities of bone metabolism in patients with multiple myeloma // Saratov Journal of Medical Scientific Research, Vol. 6, Issue 1, 2010, pp. 48-52